146 related articles for article (PubMed ID: 7527631)
21. Scanning electron microscopy of experimental keratoconjunctivitis sicca in dogs: cornea and bulbar conjunctiva.
Kern TJ; Erb HN; Schaedler JM; Dougherty EP
Vet Pathol; 1988 Nov; 25(6):468-74. PubMed ID: 3212890
[TBL] [Abstract][Full Text] [Related]
22. Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study.
Rolando M; Terragna F; Giordano G; Calabria G
Ophthalmologica; 1990; 200(4):170-6. PubMed ID: 2367078
[TBL] [Abstract][Full Text] [Related]
23. A proposed mechanism for increased tear-film osmolarity in contact lens wearers.
Gilbard JP; Gray KL; Rossi SR
Am J Ophthalmol; 1986 Oct; 102(4):505-7. PubMed ID: 3766668
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of the type 1 growth factor receptor family in the conjunctival epithelium of patients with keratoconjunctivitis sicca.
Liu Z; Carvajal M; Carothers Carraway CA; Carraway KL; Pflugfelder SC
Am J Ophthalmol; 2000 Apr; 129(4):472-80. PubMed ID: 10764856
[TBL] [Abstract][Full Text] [Related]
25. Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial.
Sheppard JD; Singh R; McClellan AJ; Weikert MP; Scoper SV; Joly TJ; Whitley WO; Kakkar E; Pflugfelder SC
Cornea; 2013 Oct; 32(10):1297-304. PubMed ID: 23884332
[TBL] [Abstract][Full Text] [Related]
26. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
Izci C; Celik I; Alkan F; Erol M; Sur E
Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
[TBL] [Abstract][Full Text] [Related]
27. Treatment of severe keratoconjunctivitis sicca by parotid duct transposition after tympanic neurectomy in rabbits.
Chen ZY; Jie Y; Yu GY
Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6964-70. PubMed ID: 21828155
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Trabodenoson in a Mouse Keratoconjunctivitis Sicca (KCS) Model for Dry-Eye Syndrome.
Žiniauskaite A; Ragauskas S; Hakkarainen JJ; Rich CC; Baumgartner R; Kalesnykas G; Albers DS; Kaja S
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3088-3093. PubMed ID: 30025146
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a physiological tear substitute in patients with keratoconjunctivitis sicca.
Nelson JD; Drake MM; Brewer JT; Tuley M
Adv Exp Med Biol; 1994; 350():453-7. PubMed ID: 8030518
[No Abstract] [Full Text] [Related]
30. The ocular surface in keratoconjunctivitis sicca.
Bron AJ; Mengher LS
Eye (Lond); 1989; 3 ( Pt 4)():428-37. PubMed ID: 2606217
[TBL] [Abstract][Full Text] [Related]
31. Effect of once daily topical 0.3% naltrexone on tear parameters and corneal sensitivity in dogs with uncontrolled keratoconjunctivitis sicca: a double-masked randomized placebo-controlled clinical trial.
Chen T; Powell CC
Vet Ophthalmol; 2015 Nov; 18(6):497-501. PubMed ID: 25675975
[TBL] [Abstract][Full Text] [Related]
32. Experimentally induced dry eye produces ocular surface inflammation and epithelial disease.
Dursun D; Wang M; Monroy D; Li DQ; Lokeshwar BL; Stern M; Pflugfelder SC
Adv Exp Med Biol; 2002; 506(Pt A):647-55. PubMed ID: 12613973
[No Abstract] [Full Text] [Related]
33. The association of conjunctival snake-like chromatin with keratoconjunctivitis SICCA.
Rivas L; Oroza MA; Sanz AI; Chen Z; Shalaby O; Murube J
Eur J Ophthalmol; 1998; 8(4):217-23. PubMed ID: 9891892
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
Kaswan RL; Salisbury MA; Ward DA
Arch Ophthalmol; 1989 Aug; 107(8):1210-6. PubMed ID: 2757551
[TBL] [Abstract][Full Text] [Related]
35. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca.
Nelson JD; Farris RL
Arch Ophthalmol; 1988 Apr; 106(4):484-7. PubMed ID: 2451494
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of tear secretion and treatment of dry-eye disease with 3-isobutyl-1-methylxanthine.
Gilbard JP; Rossi SR; Heyda KG; Dartt DA
Arch Ophthalmol; 1991 May; 109(5):672-6. PubMed ID: 1709002
[TBL] [Abstract][Full Text] [Related]
37. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
Pflugfelder SC; Maskin SL; Anderson B; Chodosh J; Holland EJ; De Paiva CS; Bartels SP; Micuda T; Proskin HM; Vogel R
Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229
[TBL] [Abstract][Full Text] [Related]
38. Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine.
Bounous DI; Krenzer KL; Kaswan RL; Hirsh SG
Adv Exp Med Biol; 1998; 438():997-1000. PubMed ID: 9635001
[No Abstract] [Full Text] [Related]
39. Assessment of tear film osmolarity using the TearLab
Sebbag L; Park SA; Kass PH; Maggs DJ; Attar M; Murphy CJ
Vet Ophthalmol; 2017 Jul; 20(4):357-364. PubMed ID: 27761982
[TBL] [Abstract][Full Text] [Related]
40. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
Marsh P; Pflugfelder SC
Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
